- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02619240
Application of GeneXpert on Bronchoscopic Samples in the Clinical Management of Patients Suspicious of TB
April 16, 2019 updated by: To Kin Wang, Chinese University of Hong Kong
This is a case control observational study using Bronchial-alveolar lavage (BAL) as specimen for GeneXpert, a real time polymerase chain reaction (PCR) test for detection of tuberculosis (TB).
Patients suspicious of TB, who require bronchoscopy as part of the investigation procedures, will be recruited for this study over a period of 18 months.
Clinical likelihood of TB will be systematically scored according to various clinical parameters.
This will determine the pre-test probability.
Clinician will decide if anti-TB treatment is to be started and patients will be followed up for a minimal of 18 months.
Sensitivity, specificity, positive, negative predictive values and the respective likelihood ratio will be calculated accordingly.
Study Overview
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Shatin, Hong Kong
- Department of Medicine and Therapeutics, Prince of Wales Hospital, CUHK
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
adult patients with abnormal chest imaging suspected of TB as a differential diagnosis
Description
Inclusion Criteria:
- Patients > 18 years old suspected of TB clinically.
- Patients suspected of TB but both smear microscopy and TB PCR of sputum are negative or sputum cannot be produced.
- BAL samples obtained following standard investigation procedure
- CXR or CT imaging available.
Exclusion Criteria:
- Bronchoscopy is not planned as a necessary procedure for investigation.
- Diagnosis of active TB has been made by other means.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
patients suspected of TB
patients suspected of TB requiring to undergo bronchoscopy as part of the investigation
|
performance of bronchoscopy with BAL
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The number of true positive BAL PCR using GeneXpert on BAL for rapid diagnosis of TB in few hours compare to the conventional TB PCR which usually take up few days to perform
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kin Wang To, MBChB, Honoary clinical assistant professor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2015
Primary Completion (Actual)
April 30, 2017
Study Completion (Actual)
August 30, 2017
Study Registration Dates
First Submitted
November 23, 2015
First Submitted That Met QC Criteria
November 30, 2015
First Posted (Estimate)
December 2, 2015
Study Record Updates
Last Update Posted (Actual)
April 17, 2019
Last Update Submitted That Met QC Criteria
April 16, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CREC 2014.556
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.